Abstract
A randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Peru. AB+IZ combination is no better than AB monotherapy, as far as efficacy and tolerability are concerned. No antagonism was detected.
mucocutaneous leishmaniasis; treatmetn; amphotericin B; itraconazole
A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis
Luis Valda Rodriguez1
Jean-Pierre Dedet2
Virginia Paredtes1
Carmelo Mendoza1
Fernando Cardenas1
Hospital de Clinicas Universitario, Servicio de Dermatologia, Miraflores, Bolivia
Insituto Boliviano de Biologia de Altura, La Paz, Bolívia
A randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Peru. AB+IZ combination is no better than AB monotherapy, as far as efficacy and tolerability are concerned. No antagonism was detected.
Full text available only in PDF format.
Texto completo disponível apenas em PDF.
Publication Dates
-
Publication in this collection
01 June 2009 -
Date of issue
Aug 1995
